We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$133M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow %
97.44%
Top 10 Hldgs %
71.03%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$15.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.3M
3
TSLA icon
Tesla
TSLA
+$12.9M
4
AGN
Allergan plc
AGN
+$8.63M
5
BX icon
Blackstone
BX
+$8.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.88%
2 Consumer Discretionary 14.07%
3 Financials 6.75%
4 Communication Services 0.35%
5 Technology 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLTI
51
DELISTED
QLT Inc
QLTI
$44K 0.03%
+10,993
New +$42.9K
RMTI icon
52
Rockwell Medical
RMTI
$27.2M
$43K 0.03%
+38
New +$39K
HRTX icon
53
Heron Therapeutics
HRTX
$93.4M
$33K 0.02%
+3,275
New +$26.7K
SNMX
54
DELISTED
Senomyx, Inc.
SNMX
$31K 0.02%
+5,108
New +$32.8K
NSPH
55
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$30K 0.02%
+3,850
New +$35.9K
AST
56
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$4K ﹤0.01%
+1,250
New +$5.03K
BTX.WS
57
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$2K ﹤0.01%
+1,529
New +$1.66K
1 2
3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for JW Asset Management, which disclosed 57 positions worth $133M. Its ten largest holdings account for 71% of the portfolio.

Its largest position is Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, followed by Consumer Discretionary and Financials.

  • JW Asset Management's largest Q4 2014 buy was Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.
  • JW Asset Management's ten largest holdings make up 71% of its $133M portfolio in Q4 2014.
  • JW Asset Management disclosed 57 positions in Q4 2014, its first 13F filing on record.

Based on JW Asset Management's 13F filing for Q4 2014, filed 5 Feb 2015.